Halvor Sommerfelt

Generating author description...

All published works

Action	Title	Year	Authors
+	Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential	2020	Philip R. Krause Thomas R. Fleming Susan S. Ellenberg Ana María Henao-Restrepo PR Krause Thomas R. Fleming MM Alejandria Balram Bhargava Susan S. Ellenberg Patricia García
+	Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers	2020	Myron M. Levine Salim Abdullah Yaseen M. Arabi Delese Mimi Darko Anna P. Durbin Vicente Estrada Euzebiusz Jamrozik Peter G. Kremsner Rosanna Lagos Punnee Pitisuttithum
+ PDF Chat	Case/Control Studies With Follow-up: Constructing the Source Population to Estimate Effects of Risk Factors on Development, Disease, and Survival	2012	Halvor Sommerfelt Hans Steinsland Lize van der Merwe William C. Blackwelder Dilruba Nasrin Tamer H. Farag Karen L. Kotloff Myron M. Levine Håkon K. Gjessing
+	Prevalence of iron deficiency and anemia among healthy women of reproductive age in Bhaktapur, Nepal	2006	Ram K. Chandyo Tor A. Strand Rune J. Ulvik Ramesh Kant Adhikari Manjeswori Ulak H Dixit Halvor Sommerfelt

Common Coauthors

Coauthor	Papers Together
Ana María Henao-Restrepo	2
Myron M. Levine	2
Philip R. Krause	2
Rosanna Lagos	1
MM Alejandria	1
Tor A. Strand	1
Yaseen M. Arabi	1
Ram K. Chandyo	1
Karen L. Kotloff	1
Deborah King	1
Susan S. Ellenberg	1
Rune J. Ulvik	1
AM Henao-Restrepo	1
Peter G. Kremsner	1
M. Cristina Cassetti	1
Sheng-Li Shi	1
Tamer H. Farag	1
Sudhanshu Vrati	1
William C. Blackwelder	1
Punnee Pitisuttithum	1
Håkon K. Gjessing	1
Patricia García	1
Ira M. Longini	1
Robert W. Sauerwein	1
Kanta Subbarao	1
Shobana Balasingam	1
Stanley A. Plotkin	1
Anna P. Durbin	1
John J. Treanor	1
Manjeswori Ulak	1
Salim Abdullah	1
Balram Bhargava	1
M. Lluïsa Abad Roses	1
Thomas R. Fleming	1
Ramesh Kant Adhikari	1
Dilruba Nasrin	1
Lize van der Merwe	1
Anastazia Older Aguilar	1
Edward J. Halloran	1
Charlie Weller	1
H Dixit	1
Delese Mimi Darko	1
MC Miranda Montoya	1
Euzebiusz Jamrozik	1
PR Krause	1
Hans Steinsland	1
Vicente Estrada	1

Commonly Cited References

Action	Title	Year	Authors	# of times referenced
+	Epidemiology: An introduction	2016	Kenneth J. Rothman	1
+	Data Monitoring Committees in Clinical Trials: A Practical Perspective	2002	Susan S. Ellenberg Thomas R. Fleming David L. DeMets	1
+ PDF Chat	Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial	2015	Ana María Henao-Restrepo Ira M. Longini Matthias Egger Natalie E. Dean W. John Edmunds Anton Camacho Miles W. Carroll Moussa Doumbia Bertrand Draguez Sophie Duraffour	1
+	Secondary analysis of case-control data	2005	Yannan Jiang Alastair J. Scott C. Wild	1
+	On the Distinction Between Interaction and Effect Modification	2009	Tyler J. VanderWeele	1
+ PDF Chat	Issues in data monitoring and interim analysis of trials	2005	Adrian Grant D. G. Altman Abdel Babiker Marion Campbell Felicity Clemens Janet Darbyshire Diana Elbourne S McLeer Mahesh Parmar Stuart J. Pocock	1
+	An Introduction to the Bootstrap	1994	Bradley Efron Robert Tibshirani	1
+ PDF Chat	Longitudinal Studies of Binary Response Data Following Case–Control and Stratified Case–Control Sampling: Design and Analysis	2009	Jonathan S. Schildcrout Paul J. Rathouz	1
+	Data Monitoring Committees in Clinical Trials: A Practical Perspective.	2003	Patricia M. Grambsch	1
+	Analyses of Case–Control Data for Additional Outcomes	2007	David B. Richardson Peter Rzehak Jochen Klenk Stephan K. Weiland	1
+	Statistics in Epidemiology: The Case-Control Study	1996	N. E. Breslow	1
+ PDF Chat	Modelling and Smoothing Parameter Estimation With Multiple Quadratic Penalties	2000	Simon N. Wood	1
+	Testing goodness-of-fit of the logistic regression model in case–control studies using sample reweighting	2004	Nico Nagelkerke Jeroen Smits Saskia le Cessie Hans C. van Houwelingen	1
+ PDF Chat	A Recombinant Vesicular Stomatitis Virus Ebola Vaccine	2015	Jason A. Regules John H. Beigel Kristopher Paolino Jocelyn Voell Amy R. Castellano Zonghui Hu P. Rubio Muñoz James E. Moon Richard C. Ruck Jason W. Bennett	1
+	Re‐use of case–control data for analysis of new outcome variables	2005	Marie Reilly Anna Torrång Åsa Klint	1
+ PDF Chat	Data monitoring committees: Promoting best practices to address emerging challenges	2017	Thomas R. Fleming David L. DeMets Matthew T. Roe Janet Wittes Karim A. Calis Amit N. Vora Alan Meisel Raymond P. Bain Marvin A. Konstam Michael Pencina	1
+ PDF Chat	Data Monitoring Committees: Current issues	2018	Thomas R. Fleming Susan S. Ellenberg David L. DeMets	1
+ PDF Chat	Ebola vaccination in the Democratic Republic of the Congo	2019	Chad R. Wells Abhishek Pandey Alyssa S. Parpia Meagan C. Fitzpatrick Lauren Ancel Meyers Burton H. Singer Alison P. Galvani	1
+	Covid-19 — The Law and Limits of Quarantine	2020	Wendy E. Parmet Michael S. Sinha	1
+	Extraordinary diseases require extraordinary solutions	2020	Stanley A. Plotkin Arthur L. Caplan	1
+	Even covid-19 can’t kill the anti-vaccination movement	2020	Katrina Megget	1
+	COVID-19 vaccine trials should seek worthwhile efficacy	2020	Philip R. Krause Thomas R. Fleming Ira M. Longini Ana María Henao-Restrepo Richard Peto NE Dean ME Halloran Yi Huang T. R. Fleming P.B. Gilbert	1
+	Survival and Event History Analysis: A Process Point of View	2008	Odd O. Aalen Oernulf Borgan Håkon K. Gjessing	1